Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 99

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 99
---
     |         | [   ] | % |     | $                    | [   ] |
| Total        |     |                  | [   ] |     |         | 100.0 | % |     | $             | [   ] |     |         | 100.0 | % |     | $                    | [   ] |

<div align='center'>53

CORPORATE HISTORY AND STRUCTURE</div>

Our Corporate History

We are an exempted company incorporated with limited liability under the laws of the Cayman Islands on May 7, 2024 with operations conducted through primarily our Hong Kong subsidiary, Living Homeopathy Hong Kong.

The Company was incorporated in connection with a reorganization for the proposed initial public offering. The Company has 50,000 authorized shares with a par value of $1 per share. On May 7, 2024, on its date of incorporation, the Company allotted and issued one share to LTO, a BVI company controlled by Mr. To.

On May 27, 2024, Living Global was incorporated in BVI with limited liability and 50,000 authorized shares at $1 per share. On its date of incorporation, Living Global allotted and issued one share to the Company at $1. Upon completion of such allotment and issue of share of Living Global to the Company, Living Global became a direct wholly-owned subsidiary of the Company.

On July 30, 2024, the entire equity interest of Living Homeopathy Hong Kong transferred from Mr. To to Living Global at nil consideration as the beneficial interest of Mr. To remain unchanged prior to and after the execution of transfer. Upon completion of such share transfer, Living Homeopathy HK became an indirect wholly-owned subsidiary of the Company.

On August 28, 2024, a shareholder
resolution of the Company was passed and approved and the article of association of the Company was amended that (i) the number of authorized
shares increased from 50,000 shares to 500,000,000 shares and divided into 450,000,000 Class A Ordinary Shares and 50,000,000 Class B
Ordinary Shares; and (ii) the par value of the shares decreased from $1 each to $0.0001 each (collectively refer as the “Share
Re-classification”). One Class A Ordinary Share represents one voting right and one Class B Ordinary Share represents fifteen voting
rights. The authorized share capital of the Company remained unchanged at $50,000. The one